Most Recent Articles about BIIB
https://www.fool.com/earnings/call-transcripts/2024/04/24/biogen-biib-q1-2024-earnings-call-transcript/?source=iedfolrf0000001
Apr 24, 2024 - BIIB earnings call for the period ending March 31, 2024.
0
fool:128492039449573275
0
https://www.zacks.com/stock/news/2258435/what-s-in-store-for-biogen-biib-this-earnings-season?cid=CS-ZC-FT-analyst_blog|earnings_preview-2258435
Apr 19, 2024 - Biogen's (BIIB) sales in the first quarter are likely to have been hurt by lower sales of its multiple sclerosis drugs, while sales of Spinraza are likely to have been moderate.
zc:-5423588768880116247
0
https://www.zacks.com/stock/news/2258367/gear-up-for-biogen-biib-q1-earnings-wall-street-estimates-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2258367
Apr 19, 2024 - Besides Wall Street's top -and-bottom-line estimates for Biogen (BIIB), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.
zc:-57921559148891070
0